This nanoparticle platform for electric field detection is the first inorganic platform to use both intensity and spectro-ratiometric (relative color change) readout for the determination of local electric fields in vitro, in vivo, and in situ.
Researchers in Dr. Dean Felsher's lab have generated a murine hepatocellular carcinoma (HCC) cell line with controllable MYC expression. HCC is one of the most common and incurable malignancies.
Researchers in Dr. Shoshana Levy's lab have created a pro B cell lines that provides the first B cell lineage tumors in a C57BL mouse strain. The cell lines, known as H11 and 2F3, were made by transducing mouse bone marrow with BCR-ABL retrovirus.
RNKp30 monoclonal antibodies were generated by immunizing BALB/c mice with rNKp30-Fc fusion protein. The rNKp30-Fc fusion protein is a soluble protein consisting of the extracellular domain of rNKp30 fused to the Fc domain of human IgG1.
Rat monoclonal antibody BZ332 specifically recognizes human serpentine protein CMKLR1. CMKLR1 is a novel protein possessing high homology with members of the chemoattractant receptor family, and binds the chmoattractant chemerin.
Monoclonal antibody that recognizes MLL, an oncoprotein that is mutated in a broad subset of pediatric and adult leukemias. MLL protein displays histone methyltransferase activity.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Meis monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.